Our magazine is free!

for living with diabetes

Diabetes medication Articles »

Diabetes medication such as Levemir, Victoza, Lantus, Metformin.

Well treated, a look at some of the newer treatments and trials for diabetes

Monday, July 15th, 2019 | 0 Comments
New diabetes treatments can be hard to keep track of. Here we take a look at some of the newer treatments and trials for diabetes. By Angela Coffey. Being armed with the basic facts about new and potential treatments is a great way read more »

Pre-bolusing is back

Monday, April 23rd, 2018 | 0 Comments
In a report entitled, Optimal prandial timing of bolus insulin in diabetes management: a review, looked at data from several studies and concluded that taking rapid-acting insulin 15–20 minutes before a meal provides significant improvements in post-meal control and was recommend by the read more »

Adocia (fast-acting insulin backed by Eli Lilly) on hold

Thursday, April 13th, 2017 | 0 Comments
Eli Lilly has decided to terminate its partnership with Adocia for the development of BioChaperone Lispro, an ultra-rapid insulin for diabetes. Despite results from 6 clinical studies indicating that Adocia’s ultra-rapid insulin performs better than Eli Lilly’s Humalog, the big American pharma has read more »

Novo Nordisk and Glooko partner up

Wednesday, February 22nd, 2017 | 0 Comments
Novo Nordisk and Glooko have announced that the two companies will work together to deliver jointly-developed and branded digital health solutions for people with diabetes. The non-exclusive collaboration will combine Novo Nordisk’s deep knowledge of diabetes with Glooko’s digital platform and data read more »

Faster insulin, soon

Wednesday, February 1st, 2017 | 0 Comments
Faster insulin The Committee for Medicinal Products for Human Use (CHMP) under the European Medicines Agency (EMA), has recommended marketing authorisation for Novo Nordisk Fiasp (fast-acting insulin aspart) for use in the treatment of adults with Type 1 and Type 2 diabetes. The read more »

Metformin and gene variants

Monday, December 19th, 2016 | 0 Comments
Researchers in an international study have uncovered new genetic evidence of how the benefits of the world’s most commonly used Type 2 diabetes drug may vary between individuals. Metformin, the drug used by hundreds of millions of people with Type 2 diabetes read more »

Glycogen powder in development

Wednesday, August 3rd, 2016 | 0 Comments
A glucogen powder now in development by Eli Lilly to treat dangerously low blood sugar in patients with Type 1 diabetes, the goal being to replace the large needles now available (but seldom used) to inject glucogen during hypoglycaemic attacks with an read more »

New insulin approved by FDA

Friday, June 3rd, 2016 | 0 Comments
Novo Nordisk has announced that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the US Food and Drug Administration (FDA) voted 16-0, recommending the approval of IDegLira for the treatment of adults with Type 2 diabetes. IDegLira is a once-daily, single read more »

Oral insulin pill possible

Wednesday, June 1st, 2016 | 0 Comments
Nadav Kidron, CEO of Oramed Pharmaceuticals, shows an insulin pill as he poses for a photo at the company’s offices in Jerusalem September 29, 2013. REUTERS/Baz Ratner As reported by Reuters, tiny Israeli drugmaker Oramed Pharmaceuticals Inc on Wednesday said its experimental oral read more »

Disappointing sales for Sanofi in diabetes care arena

Thursday, January 7th, 2016 | 0 Comments
Sanofi will focus less on diabetes monitoring devices, Chief Executive Officer Olivier Brandicourt said at the end of October (2015) after projecting disappointing sales for the company’s treatments for the disease, including two new products. Sanofi projects that diabetes sales will probably read more »